Genomma Lab brings back founder as CEO while Genomma Lab stock costs EUR 0.68

Published on 10/19/2026 at 10:28 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Rodrigo Herrera returns as interim CEO in January 2027. Genomma Lab stock costs EUR 0.68 on October 19, 2026 at Lang & Schwarz.

Leadership and reporting dates

Rodrigo Herrera is due to return as interim chief executive on January 1, 2027.
Second-quarter revenue reached MXN 4.397 billion, down 6 percent year over year.
Genomma Lab stock trades at EUR 0.68 at 10:19 a.m. CEST at Lang & Schwarz on October 19, 2026.
Third-quarter results are scheduled for October 21, 2026.

Genomma Lab, MX01LA010006, Illustration mit AI erstellt.

Genomma Lab stock was trading at EUR 0.68 at Lang & Schwarz on October 19, 2026 at 10:19 a.m. CEST. El Fondo reported on October 15, 2026 that founder Rodrigo Herrera will return as interim chief executive in January 2027, with a planned tenure of 12 to 18 months.

Founder returns in 2027

Herrera is expected to take over on January 1, 2027, while current chief executive Juan Marco Sparvieri remains in charge through the end of 2026. The transition comes as Genomma Lab works on an operating model using artificial intelligence across marketing, sales, supply chain and finance, according to El Fondo.

The same report said revenue for the second half of 2026 reached MXN 8.588 billion, down 5.5 percent from the comparable period, while EBITDA fell 11.4 percent to MXN 1.915 billion. Those figures make execution and profitable growth central tests for the incoming leadership.

What does the next quarter test?

Genomma Lab's second-quarter 2026 net sales fell 6 percent year over year to MXN 4.397 billion, while net income rose 5.5 percent to MXN 374.493 million, according to Investing.com. The gross margin expanded to 64.6 percent, but the EBITDA margin contracted to 21.8 percent.

Three dated milestones

On July 22, 2026, Genomma Lab released second-quarter results with revenue of MXN 4.397 billion, as reported in the company's financial summary by Investing.com. On September 17, 2026, the company announced the CEO transition. On October 15, 2026, it announced an Investor Day for December 3, 2026, in New York, according to PR Newswire.

Dates that matter next

Yahoo Finance reported that third-quarter 2026 results are scheduled for October 21, 2026, after the Mexican Stock Exchange closes. The conference call is set for October 22, 2026, at 11:00 a.m. Mexico City time.

BMV valuation remains the counterpoint

On the Mexican Stock Exchange, the stock last closed at MXN 14.19 on October 16, 2026. Investing.com lists a 12-month average analyst target of MXN 21.33, representing 50.34 percent above that close, while its reported market capitalization was MXN 13.8 billion as of October 19, 2026.

At Lang & Schwarz, Genomma Lab was trading at EUR 0.68 on October 19, 2026 at 10:19 a.m. CEST. The leadership change, the October reporting date and the margin trend now give investors three measurable checkpoints for the next phase.

The further course of trading is shown by the continuously updated real-time quote of Genomma Lab stock.